Measurement, outcomes and interventions of cognitive function after breast cancer treatment: A narrative review

被引:13
作者
Jia, Miaomiao [1 ]
Zhang, Xiaojun [1 ]
Wei, Liyuan [1 ]
Gao, Jinnan [1 ]
机构
[1] Shanxi Bethune Hosp, Dept Breast Surg, 99 Longcheng St, Taiyuan 030000, Shanxi, Peoples R China
关键词
assessment methods; breast cancer; cognitive impairment; intervention; mechanism; DOSE ADJUVANT CHEMOTHERAPY; NEUROPSYCHOLOGICAL PERFORMANCE; SYSTEMIC THERAPY; APOLIPOPROTEIN-E; DOUBLE-BLIND; FEATURES; 10; DNA-DAMAGE; IMPAIRMENT; SURVIVORS; WOMEN;
D O I
10.1111/ajco.13484
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer-related cognitive impairment (CRCI) is a common complaint in breast cancer patients, especially related to chemotherapy. It is characterized as cognitive disorders in areas of memory, attention and executive function, which can negatively affect patients' quality of life and their ability to work. While various assessment methods of CRCI cause highly diverse results in CRCI-related studies. Currently, it is not clear how cerebral structure and function change in breast cancer patients and underlying mechanisms of developing CRCI are still undefined. Intervention research is limited. This article reviews the results of CRCI-related studies and research progress and discusses the advantages and limits of various methods. Besides, the mechanisms and intervention strategies are reviewed.
引用
收藏
页码:321 / 329
页数:9
相关论文
共 84 条
[1]   The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy [J].
Ahles, TA ;
Saykin, AJ ;
Noll, WW ;
Furstenberg, CT ;
Guerin, S ;
Cole, B ;
Mott, LA .
PSYCHO-ONCOLOGY, 2003, 12 (06) :612-619
[2]  
Ahles TA, 2002, CLIN BREAST CANCER, V3, pS84
[3]   Reliable change in neuropsychological assessment of breast cancer survivors [J].
Andreotti, Charissa ;
Root, James C. ;
Schagen, Sanne B. ;
McDonald, Brenna C. ;
Saykin, Andrew J. ;
Atkinson, Thomas M. ;
Li, Yuelin ;
Ahles, Tim A. .
PSYCHO-ONCOLOGY, 2016, 25 (01) :43-50
[4]  
[Anonymous], 2014, A Summary Report: National Kidney Disease Education Program
[5]   Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins [J].
Asakawa, Hideki ;
Koizumi, Hirotaka ;
Koike, Ayaka ;
Takahashi, Makiko ;
Wu, Wenwen ;
Iwase, Hirotaka ;
Fukuda, Mamoru ;
Ohta, Tomohiko .
BREAST CANCER RESEARCH, 2010, 12 (02)
[6]   Variations in systemic biomarkers of oxidative/nitrosative stress and DNA damage before and during the consequent two cycles of chemotherapy in breast cancer patients [J].
Atukeren, Pinar ;
Yavuz, Berna ;
Soydinc, Hilal Oguz ;
Purisa, Sevim ;
Camlica, Hakan ;
Gumustas, M. Koray ;
Balcioglu, Ibrahim .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (10) :1487-1495
[7]   Patterns of change in cognitive function with anastrozole therapy [J].
Bender, Catherine M. ;
Merriman, John D. ;
Gentry, Amanda L. ;
Ahrendt, Gretchen M. ;
Berga, Sarah L. ;
Brufsky, Adam M. ;
Casillo, Frances E. ;
Dailey, Meredith M. ;
Erickson, Kirk I. ;
Kratofil, Frances M. ;
McAuliffe, Priscilla F. ;
Rosenzweig, Margaret Q. ;
Ryan, Christopher M. ;
Sereika, Susan M. .
CANCER, 2015, 121 (15) :2627-2636
[8]   Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis [J].
Bernstein, Lori J. ;
McCreath, Graham A. ;
Komeylian, Zahra ;
Rich, Jill B. .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2017, 83 :417-428
[9]   Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study [J].
Biglia, N. ;
Bounous, V. E. ;
Malabaila, A. ;
Palmisano, D. ;
Torta, D. M. E. ;
D'Alonzo, M. ;
Sismondi, P. ;
Torta, R. .
EUROPEAN JOURNAL OF CANCER CARE, 2012, 21 (04) :485-492
[10]   Effect of aerobic exercise on cancer-associated cognitive impairment: A proof-of-concept RCT [J].
Campbell, K. L. ;
Kam, J. W. Y. ;
Neil-Sztramko, S. E. ;
Liu Ambrose, T. ;
Handy, T. C. ;
Lim, H. J. ;
Hayden, S. ;
Hsu, L. ;
Kirkham, A. A. ;
Gotay, C. C. ;
McKenzie, D. C. ;
Boyd, L. A. .
PSYCHO-ONCOLOGY, 2018, 27 (01) :53-60